Clik here to view.
U.S. FDA Grants Priority Review to Takeda’s Ixazomib for Patients with...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review status to the New...
View ArticleClik here to view.
Visterra, Inc. and Serum Institute of India Ltd. Announce Collaboration to...
CAMBRIDGE, Mass. & PUNE, India Visterra, Inc., a clinical-stage biotechnology company that uses its proprietary technology platform to identify unique disease targets and design novel...
View ArticleClik here to view.
Nitrogen Use Efficient Rice Demonstrates an Average Yield Increase of 30...
DAVIS, Calif. & PALMIRA, Colombia & NAIROBI, Kenya Four years of field trials with a leading line of Nitrogen Use Efficient (NUE) rice have demonstrated an average 30 percent yield increase...
View ArticleClik here to view.
PanTheryx and Dr. Reddy’s Announce an Agreement to Market PanTheryx’s...
BOULDER, Colo. & HYDERABAD, India PanTheryx, Inc., a global medical nutrition company based in Boulder, Colorado, and Dr. Reddy’s Laboratories Ltd. (NYSE: RDY), a leading global pharmaceutical...
View ArticleClik here to view.
Acelity Partners with GHD to Expand Access to Advanced Wound Dressing...
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, today announced that it has entered into a strategic commercial partnership with GHD GesundHeits GmbH Deutschland (GHD) to...
View ArticleClik here to view.
武田公司用于复发/难治多发性骨髓瘤患者的 ixazomib列入美国FDA优先评审
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(TSE: 4502)今天宣布，ixazomib已列入美国食品药品管理局(FDA)的新药申请(NDA)优先评审，ixazomib是首个口服蛋白酶体抑制剂类研究药物，用于治疗复发和/或难治多发性骨髓瘤患者。 武田法规事务副总裁Melody Brown表示：“美国和欧洲的监管部门都认定，ixazomib...
View ArticleClik here to view.
Gencia and Takeda Team to Discover and Develop Novel Class of Mitochondrial...
CHARLOTTESVILLE, Va. & OSAKA, Japan Gencia LLC and Takeda Pharmaceutical Company Limited announced today a partnership to develop a new class of small molecule drugs as potential treatments for...
View ArticleClik here to view.
U.S. FDA Accepts First Digital Medicine New Drug Application for Otsuka and...
TOKYO & REDWOOD CITY, Calif. Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announced that the United States Food and Drug Administration (FDA) has...
View ArticleClik here to view.
雅培斥资2.5亿美元收购Jean Boulle集团控股的二尖瓣生产商Tendyne Holdings，印证该集团从采矿到医疗技术都能取得重大发现
卢森堡 Jean Boulle集团(www.jeanboullegroup.com) 下属的医疗技术公司和Tendyne Holdings, Inc. (“Tendyne”)的创始投资者Jean Boulle Medtech Ltd欣然宣布，雅培公司(Abbott Laboratories, NYSE: ABT) 已经完成对Tendyne...
View ArticleClik here to view.
Global Launch of ExactechGPS® Gains Early Surgeon Acceptance
GAINESVILLE, Fla. Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, reported today that surgeons around the world are...
View ArticleClik here to view.
Article 1
ルクセンブルク （ビジネスワイヤ） — Jean Boulleグループ（www.jeanboullegroup.com）の医療技術企業でTendyne Holdings, Inc.（以下「Tendyne」）の設立時投資企業であるJean Boulle Medtech Ltd は、アボット・ラボラトリーズ（NYSE:...
View ArticleClik here to view.
4年农田试验显示，具有氮利用效率的稻米平均增产30%
加州戴维斯、哥伦比亚帕尔米拉和肯尼亚内罗毕 (美国商业资讯)–为期4年的农田试验显示，一株领先的氮利用效率(NUE)稻米的产量比传统对照组平均高30%。今天，农业技术公司Arcadia Biosciences,...
View ArticleClik here to view.
The World Egg Bank Now Offers the Most Advanced Genetic Testing Available in...
PHOENIX The World Egg Bank Inc. has announced the first testing of banked egg donors and recipients to reduce the incidence of having a child with a genetic disease. The World Egg Bank has partnered...
View ArticleClik here to view.
浜松ホトニクスが科学計測用CMOSカメラ「ORCA-Flash4.0 V2」の感度（量子効率）を大幅に向上
浜松 （ビジネスワイヤ） — 浜松ホトニクス株式会社（東証：6965）は、発売以来、多くの研究者を満足させてきた科学計測用のデジタルCMOSカメラ「ORCA-Flash4.0 V2」をイメージセンサチップから再構築し、量子効率を大幅に向上（従来品に比べ10 ％以上向上：600...
View ArticleClik here to view.
Jubilant DraxImage Signs Term Sheet with Cyclopharm for Exclusive License to...
MONTREAL & SYDNEY Jubilant DraxImage Inc. (“DraxImage”) and Cyclopharm Limited (“CYC”) are pleased to announce the signing of a term sheet, subject to satisfactory due diligence and execution of...
View ArticleClik here to view.
PeptiDream Announces Peptide Discovery Collaboration Agreement with Sanofi
TOKYO PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) today announced a multi-target discovery and optimization collaboration with Sanofi, Paris, France...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Signs Commercialization Deal with Hatchtech
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) today announced the signing of a commercialization deal with Hatchtech, an Australian pharmaceutical company developing an innovative...
View ArticleClik here to view.
VPS Healthcare第三届国际肿瘤会议吸引900多位代表与会
阿拉伯联合酋长国阿布扎比 (美国商业资讯)–综合性医疗保健提供商VPS Healthcare召开了其第三届国际肿瘤会议，会议主题是“通过早期检测和预防为癌症治疗导航”。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿： http://www.businesswire.com/news/home/20150914005450/zh-CN/ VPS...
View ArticleClik here to view.
米FDA、再発性／難治性多発性骨髄腫患者に対する武田薬品のイキサゾミブに優先審査の指定を与える
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ）– 武田薬品工業株式会社（TSE: 4502）は本日、米食品医薬品局（FDA）がイキサゾミブの新薬承認申請（NDA）に優先審査の指定を与えたと発表しました。イキサゾミブは再発性もしくは難治性または両方の多発性骨髄腫を抱える患者の治療を目的とする初の経口プロテアソーム阻害薬としての治験薬です。...
View ArticleClik here to view.
Pelican BioThermal Announces Partnership with Zuellig Pharma in Asia
MINNEAPOLIS Pelican BioThermal™, a global leader providing the broadest and most innovative range of temperature-controlled packaging solutions serving the life sciences industry, announced its new...
View Article